Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ikonomopoulou, MP"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Malaysian and Chinese King Cobra Venom Cytotoxicity in Melanoma and Neonatal Foreskin Fibroblasts Is Mediated by Age and Geography.
    Autorzy:
    Op den Brouw B; Venom Evolution Lab, School of Biological Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
    Fernandez-Rojo MA; Hepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.; Diamantina Institute, The University of Queensland, Brisbane, QLD 4072, Australia.
    Charlton T; Department of Natural Sciences, Manchester Metropolitan University, All Saints Building, Manchester M15 6BH, UK.
    Fry BG; Venom Evolution Lab, School of Biological Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
    Ikonomopoulou MP; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
    Pokaż więcej
    Źródło:
    Toxins [Toxins (Basel)] 2023 Sep 04; Vol. 15 (9). Date of Electronic Publication: 2023 Sep 04.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Elapid Venoms*
    Melanoma*/drug therapy
    Fibroblasts*/drug effects
    Adult ; Animals ; Humans ; Infant, Newborn ; Male ; Foreskin/cytology ; Geography ; Ophiophagus hannah
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The structural conformation of the tachykinin domain drives the anti-tumoural activity of an octopus peptide in melanoma BRAF .
    Autorzy:
    Moral-Sanz J; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, Madrid, Spain.
    Fernandez-Rojo MA; Hepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food, Madrid, Spain.; Hepatic Fibrosis Group, Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Diamantina Institute, The University of Queensland, St. Lucia, Queensland, Australia.
    Colmenarejo G; Biostatistics & Bioinformatics Unit, Madrid Institute for Advances Studies in Food, Madrid, Spain.
    Kurdyukov S; Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre, Centenary Institute, and School of Life and Environmental Sciences, University of Sydney, Camperdown, New South Wales, Australia.
    Brust A; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.
    Ragnarsson L; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.
    Andersson Å; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.
    Vila SF; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, Madrid, Spain.; Department of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, Lugo, Spain.
    Cabezas-Sainz P; Department of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, Lugo, Spain.
    Wilhelm P; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.
    Vela-Sebastián A; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, Madrid, Spain.
    Fernández-Carrasco I; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, Madrid, Spain.
    Chin YKY; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.; Centre for Advanced Imaging, The University of Queensland, St Lucia, Queensland, Australia.
    López-Mancheño Y; Hepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food, Madrid, Spain.
    Smallwood TB; School of Biomedical Sciences, The University of Queensland, St Lucia, Queensland, Australia.
    Clark RJ; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.; School of Biomedical Sciences, The University of Queensland, St Lucia, Queensland, Australia.
    Fry BG; School of Biological Sciences, The University of Queensland, St Lucia, Queensland, Australia.
    King GF; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Queensland, Australia.
    Ramm GA; Hepatic Fibrosis Group, Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
    Alewood PF; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.
    Lewis RJ; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.
    Mulvenna JP; Infectious Diseases Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Boyle GM; Department of Cell and Molecular Biology, Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Sanchez LE; Department of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, Lugo, Spain.
    Neely GG; Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre, Centenary Institute, and School of Life and Environmental Sciences, University of Sydney, Camperdown, New South Wales, Australia.
    Miles JJ; Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Centre for Biodiscovery and Molecular Development of Therapeutics and Centre for Biosecurity in Tropical Infectious Diseases, James Cook University, Cairns, Queensland, Australia.; The Australian Institute of Tropical Health and Medicine (AITHM), James Cook University, Cairns, Queensland, Australia.; Centre for Molecular Therapeutics, James Cook University, Cairns, Queensland, Australia.; Centre for Tropical Bioinformatics and Molecular Biology, James Cook University, Cairns, Queensland, Australia.
    Ikonomopoulou MP; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, Madrid, Spain.; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.; Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Pokaż więcej
    Źródło:
    British journal of pharmacology [Br J Pharmacol] 2022 Oct; Vol. 179 (20), pp. 4878-4896. Date of Electronic Publication: 2022 Jul 29.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antineoplastic Agents*/pharmacology
    Melanoma*/drug therapy
    Melanoma*/pathology
    Adenosine Triphosphate ; Animals ; Calcium ; Cell Line, Tumor ; Humans ; Mice ; Mutation ; Octopodiformes/chemistry ; Peptides/pharmacology ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/therapeutic use ; RNA, Messenger ; Reactive Oxygen Species ; Tachykinins/genetics ; Tachykinins/therapeutic use ; Zebrafish/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations.
    Autorzy:
    Moral-Sanz J; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.
    Fernandez-Rojo MA; Hepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.; Diamantina Institute, The University of Queensland, Brisbane, QLD 4072, Australia.; Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
    Potriquet J; Infectious Diseases Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.; AB SCIEX, 2 Gilda Court, Mulgrave, Melbourne, VIC 3170, Australia.
    Mukhopadhyay P; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
    Brust A; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
    Wilhelm P; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
    Smallwood TB; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
    Clark RJ; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
    Fry BG; School of Biological Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
    Alewood PF; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
    Waddell N; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
    Miles JJ; Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.; The Australian Institute of Tropical Health and Medicine (AITHM), James Cook University, Cairns, QLD 4811, Australia.; Centre for Molecular Therapeutics, James Cook University, Cairns, QLD 4811, Australia.; Centre for Tropical Bioinformatics and Molecular Biology, James Cook University, Cairns, QLD 4811, Australia.
    Mulvenna JP; Infectious Diseases Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
    Ikonomopoulou MP; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.; Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
    Pokaż więcej
    Źródło:
    Toxins [Toxins (Basel)] 2021 Feb 14; Vol. 13 (2). Date of Electronic Publication: 2021 Feb 14.
    Typ publikacji:
    Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Mutation*
    Antineoplastic Combined Chemotherapy Protocols/*pharmacology
    Extracellular Signal-Regulated MAP Kinases/*antagonists & inhibitors
    Mechanistic Target of Rapamycin Complex 1/*antagonists & inhibitors
    Melanoma/*drug therapy
    Protein Kinase Inhibitors/*pharmacology
    Proto-Oncogene Proteins B-raf/*genetics
    Sirolimus/*pharmacology
    Skin Neoplasms/*drug therapy
    Cell Line, Tumor ; Cell Proliferation/drug effects ; Energy Metabolism/drug effects ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Humans ; Mechanistic Target of Rapamycin Complex 1/metabolism ; Melanoma/enzymology ; Melanoma/genetics ; Melanoma/pathology ; Signal Transduction ; Skin Neoplasms/enzymology ; Skin Neoplasms/genetics ; Skin Neoplasms/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation.
    Autorzy:
    Ikonomopoulou MP; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia. maria.ikonomopoulou@imdea.org.; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia. maria.ikonomopoulou@imdea.org.; Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM + CSIC, Madrid, E28049, Spain. maria.ikonomopoulou@imdea.org.
    Fernandez-Rojo MA; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia.; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia.; Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM + CSIC, Madrid, E28049, Spain.
    Pineda SS; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia.; Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, 2052, Australia.
    Cabezas-Sainz P; Departament of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, 27002, Lugo, Spain.
    Winnen B; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia.
    Morales RAV; Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM + CSIC, Madrid, E28049, Spain.; Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Victoria, 3800, Australia.
    Brust A; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia.
    Sánchez L; Departament of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, 27002, Lugo, Spain.
    Alewood PF; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia.
    Ramm GA; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia.; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia.
    Miles JJ; QIMR, Berghofer Medical Research Institute, Herston, QLD, 4002, Australia.; School of Medicine, The University of Queensland, Herston, QLD, 4006, Australia.; Centre for Biodiscovery and Molecular Development of Therapeutics, AITHM, James Cook University, Cairns, Queensland, Australia.
    King GF; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2018 Aug 01; Vol. 8 (1), pp. 11519. Date of Electronic Publication: 2018 Aug 01.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antimicrobial Cationic Peptides/*pharmacology
    Antineoplastic Agents/*pharmacology
    Cell Death/*drug effects
    Cell Proliferation/*drug effects
    Melanoma/*drug therapy
    Signal Transduction/*drug effects
    Animals ; Cell Line, Tumor ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Heterografts ; Mice ; Neoplasm Transplantation ; Treatment Outcome ; Zebrafish
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies